Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin

Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin

Soft tissue sarcomas (STS) are a group of rare and heterogeneous cancers with few diagnostic or prognostic biomarkers. This metabolomics study aimed to identify new serum prognostic biomarkers to improve the prediction of overall survival in patients with metastatic STS. The study enrolled 24 patien...

Full description

Bibliographic Details
Main Authors: Gianmaria Miolo, Emanuela Di Gregorio, Asia Saorin, Davide Lombardi, Simona Scalone, Angela Buonadonna, Agostino Steffan, Giuseppe Corona
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
metabolomics
soft tissue sarcomas
prognosis
overall survival
biomarkers
citrulline
Online Access:https://www.mdpi.com/2072-6694/12/7/1983

Internet

https://www.mdpi.com/2072-6694/12/7/1983

Similar Items